J&J To Buy Intra-Cellular, Psychiatric Drug Caplyta For $14.6bn

Deal May Launch Anticipated Year Of Larger M&A

 
• By Joseph Haas
  
J&J flag
Johnson & Johnson inks $14.6bn proposed buyout of Intra-Cellular • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas